The company operates several proprietary Risk Evaluation and Mitigation Strategy (REMS) programs for drugs including Camzyos, Revlimid, and Pomalyst. These programs mandate restricted distribution through certified pharmacies, creating significant operational overhead and a need for robust compliance and supply chain management systems.
Filing excerpt
Camzyos is only available through a restricted program called the Camzyos REMS Program. Product distribution is limited to REMS certified pharmacies, and enrolled pharmacies must only dispense to patients who are authorized to receive Camzyos.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qcomplianceBurdenGet every 10-Q signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/b9550de1-fa06-4f02-b75a-7d5984085f57 returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.
{
"signal_id": "b9550de1-fa06-4f02-b75a-7d5984085f57",
"signal_type": "sec-10q",
"signal_subtype": "complianceBurden",
"detected_at": "2026-08-04T07:03:39.423+00:00",
"company": {
"name": "Bristol Myers Squibb",
"domain": "bms.com"
},
"data": {
"detail": "The company operates several proprietary Risk Evaluation and Mitigation Strategy (REMS) programs for drugs including Camzyos, Revlimid, and Pomalyst. These programs mandate restricted distribution through certified pharmacies, creating significant operational overhead and a need for robust compliance and supply chain management systems.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "BMY manages complex, restricted REMS distribution programs for key growth drugs",
"excerpts": "Camzyos is only available through a restricted program called the Camzyos REMS Program. Product distribution is limited to REMS certified pharmacies, and enrolled pharmacies must only dispense to patients who are authorized to receive Camzyos.",
"relevance": 0.7,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/bmy-20260630.htm",
"filing_date": "2026-07-30",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/b9550de1-fa06-4f02-b75a-7d5984085f57 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bms.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.